Health and Pharmaceuticals

SectionsFeatures , Entrepreneur Zone , Trends , News

Friday, 10 May 2013

ASX-listed health research company collapses into administration following termination of key funding deal

A publicly-listed Melbourne-based health diagnostic company conducting researching into ovarian cancer and a number of other serious diseases has collapsed following the termination of a key funding agreement. by Yolanda Redrup
 

Wednesday, 01 May 2013

Medicare levy increasing by 0.5% to fund national disability scheme – what you need to know

Prime Minister Julia Gillard has announced the Medicare levy will rise by 0.5% in order to fund the government’s National Disability Insurance Scheme. by Patrick Stafford
 

Friday, 12 April 2013

Medical research grants revamp could hit biotech SMEs hard

Changes to medical R&D grants could see the biotech sector shortchanged by up to $70 million. by Michelle Hammond
 

Wednesday, 06 February 2013

Why shareholders are listening to Cochlear again

After a torrid 2012 full of recriminations and shareholder revolt, Cochlear has hopes it has turned the corner for 2013. by Kath Walters
 

Monday, 21 January 2013

Fair Work crack down: Pharmacies targeted as industry growth slows

The Fair Work Ombudsman has launched a compliance crackdown on the pharmacy industry. by Yolanda Redrup
 

Monday, 24 December 2012

Brazilian cosmetics giant acquires Melbourne skincare business Aesop for $68 million

Australian firm Aesop has been snapped up by Brazilian cosmetics company Natura Cosmeticos in a deal worth $68 million. by Cara Waters
 

Monday, 17 December 2012

Australian medical technology firm sells to private equity after children decline family business offer

Succession planning need not always be a drawn out, messy affair. Sometimes outside investors can provide suitable solutions. by Patrick Stafford
 

Monday, 26 November 2012

Healthcare communications service company Sedco collapses despite sector strength

The healthcare market might be booming but that has not kept Sedco from collapse. by Patrick Stafford
 

Tuesday, 06 November 2012

Meet the biotech that will fund its drug development – by buying into a coal mine

Heard the one about the biotech company that became a coal miner? That's the innovative path Avexa have taken to capital raising. by James Thomson
 
Free Daily Newsletter
Please enter a valid email address